CTLT

Catalent

Halal Rating :
Uncomfortable
Last Price $63.49 Last updated:
Market Cap $11.03b
7D Change 0.01%
1 Year Change 40.3%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Nov. 11, 2024

Catalent, Inc. is a global provider of development sciences and manufacturing platforms for medicines, biologics, cell and gene therapies, and consumer health products. The company partners with pharmaceutical, biotechnology, and consumer health companies to develop and deliver better treatments to patients worldwide.

The company operates through multiple segments including Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $1.02b $1.15b - $60.0m 0.00% 5.22%
June 30, 2024 $1.3b $1.26b - $65.0m 0.00% 5.18%
March 31, 2024 $1.07b $1.16b - $65.0m 0.00% 5.62%

Company Impact

Help us evaluate Catalent's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates